Loading…
Based on limited metadata, this FDA Warning Letter issued on June 26, 2020, addresses SuperHealthGuard and Loyal Great International Ltd., companies involved in drug manufacturing or distribution. Without access to the full letter text or subject line, the specific violations cannot be detailed; however, the warning indicates regulatory concerns serious enough to warrant formal FDA action. The letter falls under FDA's drug product oversight authority, though the specific issuing office is not documented in the available metadata. Additional information from the complete Warning Letter would be needed to identify the particular compliance failures or regulatory violations cited.